drugset / Trial / NCT00836849

Sertraline Hydrochloride 100 mg Tablets, Fasting

NCT00836849

Phase 1 Completed 24 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study is to compare the rate and extent of absorption of sertraline hydrochloride 100 mg tablets (test) versus Zoloft® (reference) administered as 1 x 100 mg tablet under fasting conditions.

Timeline

Start
2002-03
Primary completion
2002-04
Completion
2002-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule 100 mg

Indications

No indication recorded.